Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. The Company develops nanoparticle technology to target autoimmune and inflammatory diseases through the induction of antigen specific immune tolerance in the liver.
Topas Therapeutics total Funding
Topas Therapeutics latest funding size
Time since last funding
|3 years ago|
Topas Therapeutics investors
|Gimv, EMBL Ventures, Boehringer Ingelheim Venture Fund, Epidarex Capital, Evotec|
When was Topas Therapeutics founded?
Topas Therapeutics was founded in 2013.
Who are Topas Therapeutics key executives?
Topas Therapeutics's key executives are John Pohlner, Erich F. Greiner and Klaus Martin.
Who are Topas Therapeutics competitors?
Competitors of Topas Therapeutics include Brii Biosciences, ViewPoint Therapeutics and Prevail Therapeutics.
Where is Topas Therapeutics headquarters?
Topas Therapeutics headquarters is located at 88 Falkenried, Hamburg.
Where are Topas Therapeutics offices?
Topas Therapeutics has offices in Hamburg and Bremen.
How many offices does Topas Therapeutics have?
Topas Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies